FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine and diagnostics. Object 1 is the use of APOA4 and ITGB3 as marker proteins for diagnosing Alzheimer's disease. Object 2 is a method for diagnosing the onset of Alzheimer's disease, involving quantitative analysis of the expression level of marker proteins APOA4 and ITGB3. Object 3 is the use of a kit for diagnosing the onset of Alzheimer's disease, where said kit contains a device for quantifying expression levels of APOA4 and ITGB3 and a buffer.
EFFECT: providing diagnosis of Alzheimer's disease using biomarkers APOA4 and ITGB3.
8 cl, 32 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| BIOMARKER AND METHODS FOR EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE | 2015 |
|
RU2687272C2 |
| MICRO-RNA-BIOMARKERS INDICATING ALZHEIMER'S DISEASE | 2012 |
|
RU2639509C2 |
| LACTOFERRIN, USED IN DIAGNOSING OR PREDICTING ALZHEIMER'S DISEASE OR DIAGNOSING PARKINSON'S DISEASE | 2016 |
|
RU2745602C2 |
| TROPOMYOSIN ISOFORMS RELATED TO ALZHEIMER'S DISEASE AND MODERATE COGNITIVE IMPAIRMENTS | 2013 |
|
RU2661022C2 |
| METHOD FOR DIFFERENTIAL LIFETIME DIAGNOSIS OF ALZHEIMER'S DISEASE | 2023 |
|
RU2821893C1 |
| INSTANT DIAGNOSTIC TEST FOR ALZHEIMER'S DISEASE | 2004 |
|
RU2426130C2 |
| METHOD FOR IDENTIFYING A GROUP OF PEOPLE WITH AN INCREASED RISK OF DEVELOPING ALZHEIMER'S DISEASE | 2021 |
|
RU2781612C1 |
| METHODS OF TREATING ALZHEIMER'S DISEASE | 2015 |
|
RU2720468C2 |
| METHOD FOR ASSESSING THE RISK OF DEVELOPING ALZHEIMER'S DISEASE USING A PANEL OF BLOOD PROTEINS | 2021 |
|
RU2794040C1 |
| METHOD OF DIAGNOSTICS OF NEURODEGENERATIVE DISEASES | 2011 |
|
RU2567665C2 |
